Clinical Trials Browser

Phase 1 × Osteosarcoma × X-Rays × Clear all

NCT04539366 2026-05-13

Testing a New Immune Cell Therapy, GD2-Targeted Modified T-cells (GD2CART), in Children, Adolescents, and Young Adults With Relapsed/Refractory Osteosarcoma and Neuroblastoma, The GD2-CAR PERSIST Trial

Phase 1 Suspended

Neuroblastoma, Osteosarcoma